NT-proBNP versus echocardiographic Markers as Predictors of cardiovascular Events in Patients with CKD G 2-4

被引：0
|
作者：
Untersteller, K. [1 ]
Rogacev, K. [2 ]
Seiler, S. [1 ]
Fliser, D. [1 ]
Heine, G. [1 ]
机构：
[1] Univ Klinikum Saarlandes, Klin Innere Med Nieren & Hochdruckkrankheiten 4, Homburg, Germany
[2] Univ Klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intens, Homburg, Germany
来源：
INTERNIST | 2015年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FV10
引用
收藏
页码：13 / 14
页数：2
相关论文
共 50 条
  • [31] Predictive value of NT-proBNP for major adverse cardiovascular events within a 6-month period in patients with acute coronary syndrome
    Ozbaltan, Ozlem Canan
    Cakmak, Sumeyye
    Sogut, Ozgur
    Az, Adem
    Ogur, Hasan
    IRISH JOURNAL OF MEDICAL SCIENCE, 2025, 194 (01) : 71 - 77
  • [32] NT-PROBNP AND HSTNT IMPROVE CARDIOVASCULAR RISK PREDICTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS, CHRONIC KIDNEY OR CARDIOVASCULAR DISEASE OR BOTH
    Jhund, Pardeep
    Claggett, Brian
    Pfeffer, Marc
    Bentley-Lewis, Rhonda
    Brenner, Barry M.
    Brunel, Patrick
    Chaturvedi, Nishi
    Desai, Akshay
    Haffner, Steven
    Parving, Hans-Henrik
    Prescott, Margaret
    Solomon, Scott
    De Zeeuw, Dick
    McMurray, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1279 - A1279
  • [33] Dynamics of NT-proBNP and ST2 levels as markers of heart failure in patients with endogenous Cushing syndrome (hypercortisolism)
    Kosharnaia, Raisa S.
    Belaya, Zhanna E.
    Zuraeva, Zamira T.
    Michurova, Marina S.
    Kalashnikov, Victor Yu.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (12) : 1387 - 1393
  • [34] NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia-A brief report from the ORIGIN trial
    Wijkman, Magnus O.
    Claggett, Brian L.
    Pfeffer, Marc A.
    Pare, Guillaume
    McQueen, Matthew
    Hess, Sibylle
    Lee, Shun Fu
    Gerstein, Hertzel C.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (07)
  • [35] The Implication of NT-proBNP in the Assessment of the Clinical Phenotype of Patients with Type 2 Diabetes Mellitus, Without Established Cardiovascular Disease
    Gastouniotis, Ioannis
    Fragoulis, Christos
    Antonopoulos, Alexis
    Kouroutzoglou, Alexandrina
    Noutsou, Marina
    Thanopoulou, Anastasia
    Chrysohoou, Christina
    Tsioufis, Konstantinos P.
    BIOMEDICINES, 2024, 12 (12)
  • [36] NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus
    Huelsmann, Martin
    Neuhold, Stephanie
    Strunk, Guido
    Moertl, Deddo
    Berger, Rudolf
    Prager, Rudolf
    Abrahamian, Heidemarie
    Riedl, Michaela
    Pacher, Richard
    Luger, Anton
    Clodi, Martin
    EUROPEAN HEART JOURNAL, 2008, 29 (18) : 2259 - 2264
  • [37] NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus
    Neuhold, S.
    Huelsmann, M.
    Strunk, G.
    Luger, A.
    Riedl, M.
    Pacher, R.
    Hammer, A.
    Clodi, M.
    Gouya, G.
    EUROPEAN HEART JOURNAL, 2008, 29 : 479 - 479
  • [38] NT-ProBNP Predicts Total Mortality, Emergency Department Visits, Hospitalization, Intensive-Care Unit Admission, and Cardiovascular Events in Hemodialysis Patients
    Chen, Yi-Hsin
    Fu, Yun-Ching
    Wu, Ming-Ju
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02)
  • [39] COMBINED USE OF SOLUBLE ST2 AND NT-PROBNP FOR PREDICTING MAJOR ADVERSE CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES AND DIVERSE RENAL FUNCTION
    Irazusta Olloquiegui, Xabier
    Mora Gutierrez, Jose Maria
    Castaneda-Infante, Laura Juliana
    Echeverria Andueza, Saioa
    Pascual Izco, Marina
    Ravassa, Susanna
    Diaz-Dorronsoro, Agnes
    Fernandez-Seara, Maria A.
    Javier Escalada, Francisco
    Garcia-Fernandez, Nuria
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I998 - I999
  • [40] The Role of NT-proBNP as a Biomarker in Evaluating Residual Cardiovascular Risk in 200 Type 2 DM Patients Optimized for Conventional CV Risk Markers over Two Years
    Gupta, Vishal
    Teli, Vaishali
    DIABETES, 2018, 67
12345